BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36899302)

  • 1. AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report.
    Schäfer J; Christensen PB; Jensen K
    BMC Neurol; 2023 Mar; 23(1):102. PubMed ID: 36899302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report.
    Luo Q; Wu X; Huang W
    BMC Neurol; 2019 Jun; 19(1):126. PubMed ID: 31195997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis.
    Li X; Mao YT; Wu JJ; Li LX; Chen XJ
    J Neuroimmunol; 2015 Apr; 281():35-7. PubMed ID: 25867465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
    Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
    JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
    Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
    Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis.
    Lin J; Wang J; Li J
    Neurol Sci; 2023 Sep; 44(9):3253-3259. PubMed ID: 37010671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cerebral atrophy in autoimmune encephalitis complicated by haemophagocytic lymphohistiocytosis.
    Wu Q; Dai S; Zhu L; Zhao CW
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-NMDA Receptor Encephalitis Masquerades as Psychosis: A Case Report.
    Giri YR; Korie I; Hashmi S; Parrill A; Ayed N
    J Psychiatr Pract; 2022 Jan; 28(1):72-77. PubMed ID: 34989349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Epilepsy.
    Gaspard N
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant course in a patient with anti-N-methyl-D-aspartate receptor encephalitis with bilateral ovarian teratomas: A case report and literature review.
    Lee KW; Liou LM; Wu MN
    Medicine (Baltimore); 2018 Apr; 97(15):e0339. PubMed ID: 29642173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes expressing neuronal autoantigens induced immune response in antibody-positive autoimmune encephalitis.
    Gu J; Jin T; Li Z; Chen H; Xia H; Xu X; Gui Y
    Mol Immunol; 2021 Mar; 131():164-170. PubMed ID: 33446390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NMDAR encephalitis with GFAPα IgG: a case report.
    Bai P; Liu B; Li M; Chun M; Ma X; Zhen J
    BMC Neurol; 2022 Nov; 22(1):424. PubMed ID: 36371153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review.
    Wei YC; Huang CC; Liu CH; Kuo HC; Lin JJ
    Brain Behav; 2017 Sep; 7(9):e00779. PubMed ID: 28948076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic review.
    Berek K; Grams A; Uprimny C; Prieschl M; Ramberger M; Unterberger I; Deisenhammer F; Reindl M; Hegen H
    BMC Neurol; 2022 Nov; 22(1):434. PubMed ID: 36384491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daratumumab for treatment-refractory antibody-mediated diseases in neurology.
    Scheibe F; Ostendorf L; Prüss H; Radbruch H; Aschman T; Hoffmann S; Blau IW; Meisel C; Alexander T; Meisel A
    Eur J Neurol; 2022 Jun; 29(6):1847-1854. PubMed ID: 35098616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
    Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
    Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.